ADC Therapeutics
ADCT
₹135.42
Share price
-2.47%
Change (1 day)
-62.65%
Change (1 year)
Categories
ADC Therapeutics (ADCT) Fails to deliver data
Key failure to deliver metrics for ADC Therapeutics:
- Last SEC data release: 2025-02-28
- Last 15 days FTD volume: ₹0.02 M
- Last 3 months FTD volume: ₹0.3 M
- Last year FTD volume: ₹0.3 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for ADC Therapeutics (ADCT) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for ADC Therapeutics (ADCT) - since 2020
Volume in USD (price x number of shares), data since 2020ADC Therapeutics (ADCT) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | ₹0.04 M | -99.59% |
| 2024 | ₹11.29 M | 157.81% |
| 2023 | ₹4.38 M | -85.72% |
| 2022 | ₹30.68 M | -35.55% |
| 2021 | ₹47.61 M | 79.6% |
| 2020 | ₹26.51 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | ₹4.56 M | ₹8.7 M | 🇺🇸 USA |